兆易创新(603986) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥1,428,675,586.88, a decrease of 28.14% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2023 was ¥97,693,933.50, down 82.71% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥65,051,821.99, a decline of 87.75% compared to the previous year[2]. - The basic earnings per share for Q3 2023 was ¥0.14, representing an 83.53% decrease year-on-year[2]. - Total operating revenue for the first three quarters of 2023 was CNY 4,394,487,650.70, a decrease of 35.4% compared to CNY 6,769,083,021.08 in the same period of 2022[15]. - Net profit for the first three quarters of 2023 was CNY 433,675,509.91, a significant decline of 79.3% from CNY 2,091,913,708.26 in the same period of 2022[16]. - Basic earnings per share for the third quarter of 2023 was CNY 0.65, compared to CNY 3.16 in the same quarter of 2022[17]. - Operating profit for the first three quarters of 2023 was approximately ¥313.85 million, down 87.0% from ¥2.42 billion in the same period of 2022[26]. - Net profit for the first three quarters of 2023 was approximately ¥318.24 million, a decline of 85.4% compared to ¥2.18 billion in the same period of 2022[26]. Assets and Liabilities - The total assets at the end of the reporting period were ¥16,972,802,873.18, an increase of 1.97% from the end of the previous year[3]. - The company's total liabilities decreased slightly to RMB 1,435,503,136.79 from RMB 1,459,533,222.40 year-over-year[13]. - The total current assets increased to RMB 11,722,766,817.53 compared to RMB 11,414,641,690.30 in the previous year[12]. - The company's total equity increased slightly to ¥14,262,654,441.92 from ¥14,244,414,639.17, showing a growth of about 0.13%[23]. - The total assets as of September 30, 2023, amounted to ¥15,524,581,908.29, a decrease from ¥15,700,744,912.66 at the end of 2022, reflecting a reduction of approximately 1.1%[22]. - The company's total liabilities decreased to ¥1,261,927,466.37 from ¥1,456,330,273.49, marking a reduction of about 13.3%[23]. - The company's inventory decreased to ¥2,091,217,689.12 from ¥2,153,875,670.89, reflecting improved inventory management[12]. - The company's inventory decreased to ¥1,010,308,291.85 from ¥1,299,582,463.90, representing a reduction of approximately 22.3%[22]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥981,203,538.24, an increase of 123.11% compared to the same period last year[6]. - The net cash flow from operating activities for Q3 2023 was ¥981,203,538.24, a significant increase compared to ¥439,786,748.91 in Q3 2022, reflecting a growth of approximately 123.5%[19]. - Cash flow from operating activities for the first three quarters of 2023 was approximately ¥98.88 million, compared to ¥58.61 million in the same period of 2022, indicating a positive trend[29]. - Cash flow from investing activities showed a net outflow of approximately ¥887.82 million in the first three quarters of 2023, compared to a net inflow of ¥56.26 million in the same period of 2022[30]. Market and Product Strategy - The decline in operating revenue is primarily due to decreased market demand for chip products and lower product prices compared to last year[6]. - The company plans to focus on self-developed DRAM products, leading to a significant reduction in sales revenue from distribution products[6]. - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the report[11]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 150,805[8]. - The company has a total of 19,003,070 shares held by major shareholder Ge Weidong, indicating strong insider confidence[10]. Research and Development - Research and development expenses for the first three quarters of 2023 were CNY 756,770,461.28, an increase of 3.9% compared to CNY 728,100,306.21 in the same period of 2022[15]. - Research and development expenses increased to approximately ¥401.96 million in the first three quarters of 2023, up 7.0% from ¥375.00 million in the same period of 2022[25].